According to Natantis, researchers will be able to use the device to extract cell-free nucleic acids from whole blood in 45 minutes.
Researchers used Mission Bio's Tapestri assay to identify and monitor the evolution of cancer mutations in acute myeloid leukemia in response to targeted treatment.
The FLASH method, which depletes unwanted DNA from samples, allows labs to perform deep metagenomic sequencing on smaller, less expensive instruments.
Investigators concluded that the spiked samples from SeraCare were a robust tool for inter-lab comparisons and discussed some areas of discordance seen in the study.
The company received support from a Johns Hopkins University center focused on point-of-care device development for sexually transmitted infections.
The Australian startup, recently out of stealth mode, is reviving the concept of sequencing analysis by mutagenesis for NGS library preparation.
The two-year award will fund development and commercialization of the firm's HLS-Catch platform and follows a previous grant of $191,535.
The Australian startup emerges from stealth with former Solexa CEO Nick McCooke reprising that role at the firm.
Arcis Biotechnology and Andrew Alliance will comarket their respective technologies for automated nucleic acid stabilization and preparation.
NanoCellect's Wolf Cell Sorter and N1 single-cell plate dispenser uses lasers and piezoelectricity to gently sort cells for downstream applications.
The company will offer 3.75 million shares of its common stock at $21 per share.
New methods for spatial transcriptomic profiling include a sequential FISH-based method and one that makes use of DNA-barcoded bead arrays.
The company will use the proceeds to expand its R&D capabilities and its commercial operations.
The firm will work with investigators from the University of North Carolina at Chapel Hill and the University of Virginia to validate its AIR system in CRISPR workflows.
The Seattle-based firm's PickSeq platform integrates cell imaging and extraction tools for downstream RNA enrichment, sequencing, and targeted biomarker discovery.
The firm said that the technology contains an enclosed, sterile sorting chip that enables users to type cells according to biomarkers and sort them into separate outputs.
The recovery tool applies click chemistry-based DNA attachments on agarose beads to allow repetitive primer extension for specific gene targets.
The company, which previously focused on the development of multiplex PCR assays, is hoping to make its ATOM-seq technology available for research use later this year.
The number of US states legalizing cannabis for medical and recreational use is growing, expanding the market for pathogen detection solutions.
The SciLifeLab spinout uses barcoded probes, in situ rolling circle amplification, and sequencing by ligation to measure expression of a panel of genes.
The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.
The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.
News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.
In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.